Pharmaceutical Stone Technology (300725.SZ) plans to invest about 2 billion yuan to build the Nanjing CDMO Innovation Base

Zhitong Finance App News, Yakshi Technology (300725.SZ) issued an announcement. In order to further improve the company's industrial layout in the field of pharmaceutical CDMO, the company plans to sign an “Investment Cooperation Agreement” with Nanjing Jiangbei New Material Science Park Co., Ltd., a wholly-owned subsidiary established by the company or the New Material Science Park company to jointly fund the establishment of a project company to participate in the bid for relevant land in Nanjing Jiangbei New Material Technology Park, and promote the implementation of the Nanjing CDMO Innovation Base project after the project company competed for the target plot according to law.

According to reports, the overall investment of the project is estimated to be about 2 billion yuan, mainly including infrastructure investment by the project company, as well as investment in subsequent workshop decoration, production equipment and related operating facilities carried out by the company or the company's controlling entity as the lessee. This investment in the construction of a pharmaceutical CDMO innovation base is conducive to improving the industrial carrying system and multi-base layout of the company's business, and enhancing the flexibility of resource allocation, business continuity, and project delivery guarantee capabilities.